Furthermore, dysregulated activity of the GLP-1 inactivating enzyme DPP-4 has been found in male mice from obese mothers, but when mothers were treated with sitagliptin, the progression of the obesity phenotype was delayed in males although no effects were observed in females [62]. Here, DPP4 is linked to obesity disorder.